0000950137-01-504157.txt : 20011101 0000950137-01-504157.hdr.sgml : 20011101 ACCESSION NUMBER: 0000950137-01-504157 CONFORMED SUBMISSION TYPE: 8-K PUBLIC DOCUMENT COUNT: 2 CONFORMED PERIOD OF REPORT: 20011030 ITEM INFORMATION: Financial statements and exhibits ITEM INFORMATION: FILED AS OF DATE: 20011030 FILER: COMPANY DATA: COMPANY CONFORMED NAME: PERRIGO CO CENTRAL INDEX KEY: 0000820096 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 382799573 STATE OF INCORPORATION: MI FISCAL YEAR END: 0630 FILING VALUES: FORM TYPE: 8-K SEC ACT: 1934 Act SEC FILE NUMBER: 000-19725 FILM NUMBER: 1770128 BUSINESS ADDRESS: STREET 1: 515 EASTERN AVENUE CITY: ALLEGAN STATE: MI ZIP: 49010 BUSINESS PHONE: 6166738451 MAIL ADDRESS: STREET 1: 515 EASTERN AVENUE CITY: ALLEGAN STATE: MI ZIP: 49010 8-K 1 c65686e8-k.txt FORM 8-K SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): October 30, 2001 PERRIGO COMPANY -------------------------------------------------- (Exact name of registrant as specified in charter) MICHIGAN 0-19725 38-2799573 --------------- ------------ ----------------- (State of other (Commission (I.R.S. Employer Jurisdiction of File Number) Identification Incorporation) Number) 515 Eastern Avenue, Allegan, Michigan 49010 ------------------------------------------ ----------- (Address of principal executive offices) (Zip Code) Registrant's telephone number, including area code: (616) 673-8451 -------------- Item 7(c). Exhibits Exhibit 99 Annual Shareholders' Meeting Slides ITEM 9. Regulation FD Disclosure On October 30, 2001, The Perrigo Company held its Annual Shareholders' Meeting at the Griswold Auditorium, Allegan, Michigan. The Annual Shareholders' Meeting slides presented are Exhibit 99. Certain statements in these slides are forward-looking statements within the meaning of Section 21E of the Securities Exchange Act of 1934, as amended, and are subject to the safe harbor created thereby. Please see the "Cautionary Note Regarding Forward-Looking Statements" on pages 24 - 29 of the Company's Form 10-K for the year ended June 30, 2001 for a discussion of certain important factors that relate to forward-looking statements contained in these slides. In addition, the Company's future results may be affected by the impact of events flowing from the September 11, 2001 terrorist attacks. Although the Company believes that the expectations reflected in these forward-looking statements are reasonable, it can give no assurance that such expectations will prove to be correct. Unless otherwise required by applicable securities laws, the Company disclaims any intention or obligation to update or revise any forward-looking statements, whether as a result of new information, future events or otherwise. SIGNATURES Pursuant to the requirement of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. PERRIGO COMPANY (Registrant) By: /s/ Douglas R. Schrank ----------------------------------- Dated: October 30, 2001 Douglas R. Schrank Executive Vice President and Chief Financial Officer (Principal Accounting and Financial Officer) Exhibit Index Exhibit 99 - Annual Shareholders' Meeting Slides EX-99 3 c65686ex99.txt ANNUAL SHAREHOLDERS' MEETING SLIDES WELCOME TO THE 2001 ANNUAL MEETING OF SHAREHOLDERS [PERRIGO LOGO] ALLEGAN, MICHIGAN OCTOBER 30, 2001 [PERRIGO LOGO] STORE BRAND MARKET LEADER [PHOTO OF MEDICINE] [PERRIGO LOGO] NET SALES 1999 692 2000 727 2001 766 [BAR GRAPH] [PERRIGO LOGO] OPERATING INCOME 1999 LESS RUSSIA CHARGES 29.8 2000 35.9 2001 LESS PPA CHARGES 40.1 61.1 [BAR GRAPH] NET INCOME 1999 9.4 2000 19.3 2001 27.7 41.1 [BAR GRAPH] [PERRIGO LOGO] DILUTED EARNINGS PER SHARE 1999 $0.13 2000 $0.26 2001 $0.37 $0.55 [BAR GRAPH] [PERRIGO LOGO] STOCK PRICE FROM 6/30/00 TO 6/29/01 $6.31 TO $16.69 [A GRAPH] [PERRIGO LOGO] CYCLE OF RECOVERY Financial ------ > Operations ------ > Growth | | / | | | / | | | / | | | / | FY2000 FY2001/02 FY2002/03 [PERRIGO LOGO] [WRAFTON LABORATORIES LOGO] [PHOTO OF LABORATORIES] [PERRIGO LOGO] Rx(2) OTC SWITCH Near-term Opportunities - Advil(R) Cold/Sinus - Children's Motrin(R) Suspension New Flavors [PHOTO OF MEDICINE] - Excedrin(R) Migraine - Monistat(R) 1 - Pepcid(R) AC Chewable [PERRIGO LOGO] [PHOTO OF MEDICINE] [PERRIGO LOGO] [PHOTO OF MEDICINE] [PERRIGO LOGO] FIRST QUARTER NET SALES [BAR GRAPH] 2000 192 2001 192 2002 217 [PERRIGO LOGO] FIRST QUARTER NET INCOME [BAR GRAPH] 2000 9.6 2001 10.5 2002 13.1 [PERRIGO LOGO] FIRST QUARTER EARNINGS PER SHARE [BAR GRAPH] 2000 $0.13 2001 $0.14 2002 $0.17 [PERRIGO LOGO] [PERRIGO(R) LOGO] - Clear market leader [PERRIGO(R) LOGO] [PERRIGO(R) LOGO] - Clear market leader - Retailer relationships [PERRIGO(R) LOGO] [PERRIGO(R) LOGO] - Clear market leader - Retailer relationships - Solid financials [PERRIGO(R) LOGO] [PERRIGO(R) LOGO] - Clear market leader - Retailer relationships - Solid financials - Productivity improvement [PERRIGO(R) LOGO] [PERRIGO(R) LOGO] - Clear market leader - Retailer relationships - Solid financials - Productivity improvement - Understand the Store Brand market better than anyone [PERRIGO(R) LOGO] [PERRIGO(R) LOGO]